Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II study
- 1 March 1993
- Vol. 71 (5) , 1898-1903
- https://doi.org/10.1002/1097-0142(19930301)71:5<1898::aid-cncr2820710529>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Ifosfamide, Fanconi's syndrome, and rickets.Journal of Clinical Oncology, 1991
- Phase II Study of Ifosfamide-Etoposide-Mesna in Adults With Advanced Nonosseous SarcomasJNCI Journal of the National Cancer Institute, 1989
- Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.Journal of Clinical Oncology, 1989
- Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumorsInvestigational New Drugs, 1988
- Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.Journal of Clinical Oncology, 1987
- A phase II study of ifosfamide in the treatment of recurrent sarcomas in young peopleCancer Chemotherapy and Pharmacology, 1986
- Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patientsCancer Treatment Reviews, 1983
- High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trialCancer Treatment Reviews, 1983
- High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcomaCancer Treatment Reviews, 1983
- Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapyCancer Treatment Reviews, 1983